Search research articles
Contact Us
Filters
Showing results (431-440 of 592) with videos related to
Page
of 60
Sort By:
Nature Communications
|
August 8, 2024
Human tumor suppressor protein Pdcd4 binds at the mRNA entry channel in the 40S small ribosomal subunit
Jailson Brito Querido, Masaaki Sokabe, Irene Díaz-López, et al.
BMJ (Clinical Research Ed.)
|
August 18, 1990
Short course chemotherapy for tuberculous lymphadenitis in children
M S Jawahar, S Sivasubramanian, V K Vijayan, et al.
Cell
|
December 17, 2009
The structural basis for mRNA recognition and cleavage by the ribosome-dependent endonuclease RelE
Cajetan Neubauer, Yong-Gui Gao, Kasper R Andersen, et al.
Leukemia
|
August 10, 2011
MRK003, a γ-secretase inhibitor exhibits promising in vitro pre-clinical activity in multiple myeloma and non-Hodgkin's lymphoma
V Ramakrishnan, S Ansell, J Haug, et al.
Science (New York, N.Y.)
|
March 29, 2014
Structure of the yeast mitochondrial large ribosomal subunit
Alexey Amunts, Alan Brown, Xiao-Chen Bai, et al.
The Journal of Prevention of Alzheimer'S Disease
|
October 1, 2024
Semorinemab Pharmacokinetics and The Effect on Plasma Total Tau Pharmacodynamics in Clinical Studies
V Ramakrishnan, B Bender, J Langenhorst, et al.
Cell
|
November 24, 2014
Structural changes enable start codon recognition by the eukaryotic translation initiation complex
Tanweer Hussain, Jose L Llácer, Israel S Fernández, et al.
AJNR. American Journal of Neuroradiology
|
December 24, 2021
Quantitative Diffusion and Spectroscopic Neuroimaging Combined with a Novel Early-Developmental Assessment Improves Models for 1-Year Developmental Outcomes
H G Moss, L G Wolf, P Coker-Bolt, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire
|
November 1, 1995
Structures of prokaryotic ribosomal proteins: implications for RNA binding and evolution
V Ramakrishnan, C Davies, S E Gerchman, et al.
Oncogene
|
November 26, 2009
Sorafenib, a dual Raf kinase/vascular endothelial growth factor receptor inhibitor has significant anti-myeloma activity and synergizes with common anti-myeloma drugs
V Ramakrishnan, M Timm, J L Haug, et al.
Page
of 60
Search research articles
Search
Showing results (431-440 of 592) with videos related to
Sort By:
Page
of 60
Nature Communications
|
August 8, 2024
Human tumor suppressor protein Pdcd4 binds at the mRNA entry channel in the 40S small ribosomal subunit
Jailson Brito Querido, Masaaki Sokabe, Irene Díaz-López, et al.
BMJ (Clinical Research Ed.)
|
August 18, 1990
Short course chemotherapy for tuberculous lymphadenitis in children
M S Jawahar, S Sivasubramanian, V K Vijayan, et al.
Cell
|
December 17, 2009
The structural basis for mRNA recognition and cleavage by the ribosome-dependent endonuclease RelE
Cajetan Neubauer, Yong-Gui Gao, Kasper R Andersen, et al.
Leukemia
|
August 10, 2011
MRK003, a γ-secretase inhibitor exhibits promising in vitro pre-clinical activity in multiple myeloma and non-Hodgkin's lymphoma
V Ramakrishnan, S Ansell, J Haug, et al.
Science (New York, N.Y.)
|
March 29, 2014
Structure of the yeast mitochondrial large ribosomal subunit
Alexey Amunts, Alan Brown, Xiao-Chen Bai, et al.
The Journal of Prevention of Alzheimer'S Disease
|
October 1, 2024
Semorinemab Pharmacokinetics and The Effect on Plasma Total Tau Pharmacodynamics in Clinical Studies
V Ramakrishnan, B Bender, J Langenhorst, et al.
Cell
|
November 24, 2014
Structural changes enable start codon recognition by the eukaryotic translation initiation complex
Tanweer Hussain, Jose L Llácer, Israel S Fernández, et al.
AJNR. American Journal of Neuroradiology
|
December 24, 2021
Quantitative Diffusion and Spectroscopic Neuroimaging Combined with a Novel Early-Developmental Assessment Improves Models for 1-Year Developmental Outcomes
H G Moss, L G Wolf, P Coker-Bolt, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire
|
November 1, 1995
Structures of prokaryotic ribosomal proteins: implications for RNA binding and evolution
V Ramakrishnan, C Davies, S E Gerchman, et al.
Oncogene
|
November 26, 2009
Sorafenib, a dual Raf kinase/vascular endothelial growth factor receptor inhibitor has significant anti-myeloma activity and synergizes with common anti-myeloma drugs
V Ramakrishnan, M Timm, J L Haug, et al.
Page
of 60